<DOC>
	<DOCNO>NCT00507390</DOCNO>
	<brief_summary>This hypothesis test study , hypothesis dietary supplement n-PUFAs concentrate anti-arrhythmic ventricular arrhythmic substrate . Study Aims : To investigate whether dietary supplement n-3 polyunsaturated fatty acid concentrate ( 2g PUFAs/day , Omacor ) reduce MTWA ( surrogate endpoint ventricular arrhythmia substrate ) patient ICDs malignant ventricular arrhythmia .</brief_summary>
	<brief_title>Omega 3 Polyunsaturated Fatty Acid Supplements ( PUFAs ) Microvolt T Wave Alternans ( TWA ) Patients With Ventricular Arrhythmia</brief_title>
	<detailed_description>Patients Department Cardiology ICD out-patient clinic , Ninewells Hospital Medical School , recruit . All patient history document ventricular arrhythmia . Data previous study predict 90 % patient abnormal MTWA . A total 45 ICD patient recruit . The study design double blind randomise placebo control crossover design . A baseline MTWA test perform patient abnormal test select . The patient randomise receive fish oil supplement ( 2g/day ) placebo 8 week . At end intervention period , repeat MWTA test perform . A 10 ml venous blood sample also collect baseline , intervention period ( 3 sample total ) . Patients atrial fibrillation , frequent atrial ventricular ectopics , ventricular pacing ICD , unstable angina , NYHA IV heart failure , pregnancy child bear potential exclude study . End Points Study . The primary endpoint quantitative qualitative measure MTWA n-3 PUFAs treatment compare placebo . Statistical Analysis : Quantitative difference MTWA measurement analyse Student 's t-test qualitative difference chi square test . A probability 0.05 % consider significant .</detailed_description>
	<criteria>implantable cardiovertor defibrillator microvolt Twave alternans positive unstable angina CHF</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>fish oil</keyword>
</DOC>